Literature DB >> 15331439

Physical and functional link of the leukemia-associated factors AML1 and PML.

Lan Anh Nguyen1, Pier Paolo Pandolfi, Yukiko Aikawa, Yusuke Tagata, Misao Ohki, Issay Kitabayashi.   

Abstract

The AML1-CBFbeta transcription factor complex is the most frequent target of specific chromosome translocations in acute myeloid leukemia (AML). The promyelocytic leukemia (PML) gene is also frequently involved in AML-associated translocation. Here we report that a specific isoform PML I forms a complex with AML1. PML I was able to recruit AML1 and coactivator p300 in PML nuclear bodies and enhance the AML1-mediated transcription in the presence of p300. A specific C-terminal region of PML I and a C-terminal region of AML1 were found to be required for both their association and colocalization in the nuclear bodies. Overexpression of PML I stimulates myeloid cells to differentiate. These results suggest that PML I could act as a mediator for AML1 and its coactivator p300/CBP to assemble into functional complexes and, consequently, activate AML1-dependent transcription and myeloid cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331439     DOI: 10.1182/blood-2004-03-1185

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formation.

Authors:  Yunyun Geng; Shamci Monajembashi; Anwen Shao; Di Cui; Weiyong He; Zhongzhou Chen; Peter Hemmerich; Jun Tang
Journal:  J Biol Chem       Date:  2012-07-07       Impact factor: 5.157

2.  PML-retinoic acid receptor alpha inhibits PML IV enhancement of PU.1-induced C/EBPepsilon expression in myeloid differentiation.

Authors:  Hitoshi Yoshida; Hitoshi Ichikawa; Yusuke Tagata; Takuo Katsumoto; Kazunori Ohnishi; Yukihiro Akao; Tomoki Naoe; Pier Paolo Pandolfi; Issay Kitabayashi
Journal:  Mol Cell Biol       Date:  2007-06-11       Impact factor: 4.272

3.  PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation.

Authors:  Yutaka Shima; Takito Shima; Tomoki Chiba; Tatsuro Irimura; Pier Paolo Pandolfi; Issay Kitabayashi
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

4.  Herpes simplex virus 1 ubiquitin ligase ICP0 interacts with PML isoform I and induces its SUMO-independent degradation.

Authors:  Delphine Cuchet-Lourenço; Emilia Vanni; Mandy Glass; Anne Orr; Roger D Everett
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

5.  Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.

Authors:  Yukiko Aikawa; Lan Anh Nguyen; Kyoichi Isono; Nobuyuki Takakura; Yusuke Tagata; M Lienhard Schmitz; Haruhiko Koseki; Issay Kitabayashi
Journal:  EMBO J       Date:  2006-08-17       Impact factor: 11.598

Review 6.  Deregulated transcription factors in leukemia.

Authors:  Yutaka Shima; Issay Kitabayashi
Journal:  Int J Hematol       Date:  2011-08-09       Impact factor: 2.490

Review 7.  Significance of oncogenes and tumor suppressor genes in AML prognosis.

Authors:  Maria Kavianpour; Ahmad Ahmadzadeh; Saeid Shahrabi; Najmaldin Saki
Journal:  Tumour Biol       Date:  2016-05-14

8.  HOX expression patterns identify a common signature for favorable AML.

Authors:  M Andreeff; V Ruvolo; S Gadgil; C Zeng; K Coombes; W Chen; S Kornblau; A E Barón; H A Drabkin
Journal:  Leukemia       Date:  2008-07-31       Impact factor: 11.528

9.  PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies.

Authors:  Akio Iwanami; Beatrice Gini; Ciro Zanca; Tomoo Matsutani; Alvaro Assuncao; Ali Nael; Julie Dang; Huijun Yang; Shaojun Zhu; Jun Kohyama; Issay Kitabayashi; Webster K Cavenee; Timothy F Cloughesy; Frank B Furnari; Masaya Nakamura; Yoshiaki Toyama; Hideyuki Okano; Paul S Mischel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-25       Impact factor: 11.205

Review 10.  Post-translational modifications of Runx1 regulate its activity in the cell.

Authors:  Lan Wang; Gang Huang; Xinyang Zhao; Megan A Hatlen; Ly Vu; Fan Liu; Stephen D Nimer
Journal:  Blood Cells Mol Dis       Date:  2009-04-21       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.